Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review
Peng Ding, Huanhuan Lin, Kaichen Zhang, Qian Yang, Peiyang Gao. Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review. // BMC Pulmonary Medicine. – 2025. – DOI: 10.1186/s12890-025-03838-z. – URL: https://doi.org/10.1186/s12890-025-03838-z
Peng Ding, Huanhuan Lin, Kaichen Zhang, Qian Yang, & Peiyang Gao (2025). Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-025-03838-z
Peng Ding, et al. “Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review.” BMC Pulmonary Medicine, 2025. doi:10.1186/s12890-025-03838-z.
@article{Ding2025,
title = {Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review},
author = {Ding, Peng and Lin, Huanhuan and Zhang, Kaichen and Yang, Qian and Gao, Peiyang},
journal = {BMC Pulmonary Medicine},
year = {2025},
doi = {10.1186/s12890-025-03838-z},
url = {https://doi.org/10.1186/s12890-025-03838-z}
}